Stock listing

Frankfurt:7VR Celcuity Inc. Aktie

German listing (Frankfurt) of Celcuity Inc. · home listing NASDAQ:CELC

Follow Celcuity Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CELC

$53.35 USD -2.25 (-4.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CELC

Past year -43.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$53.20 – $57.00 USDNov 20, 2026
Volume
636,527 sharesNov 20, 2026
Market cap
$2.62B USDAt the close on Nov 20, 2026 · price × 49.13M shares outstanding
52-week range
$53.20 – $151.02 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$87.38M USDMedian day 940,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Celcuity Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CELC · Home$53.35 USD-2.25 (-4.0%)636,527$55.02$57.00$53.20$55.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CELC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$53.35-2.25-4.0%$55.02$57.00$53.20636,527
$55.60-2.41-4.2%$57.62$58.12$55.48984,323
$58.01-2.56-4.2%$60.21$60.97$56.642,208,362
$60.57-3.80-5.9%$63.84$64.87$60.40730,848
$64.37+0.20+0.3%$64.20$64.60$61.71646,495
$64.17-0.15-0.2%$63.36$65.81$60.97906,766
$64.32-2.73-4.1%$67.91$67.95$64.27696,780
$67.05-3.32-4.7%$68.96$71.00$66.20769,793
$70.37+3.58+5.4%$67.79$72.24$66.40921,953
$66.79+2.75+4.3%$67.15$67.27$62.441,052,504
$64.04-5.20-7.5%$68.28$68.77$63.441,423,629
$69.24-0.48-0.7%$72.00$72.00$67.481,188,639
$69.72+2.65+4.0%$67.13$70.99$67.001,105,548
$67.07-2.06-3.0%$69.50$70.13$66.20770,521
$69.13-0.17-0.2%$68.47$70.43$67.42700,079
$69.30-0.16-0.2%$70.66$73.29$69.00819,605
$69.46+1.39+2.0%$67.41$69.95$67.391,125,891
$68.07+2.27+3.4%$66.08$68.81$65.69885,824
$65.80+0.55+0.8%$65.50$68.39$64.921,866,245
$65.25-0.32-0.5%$65.57$66.30$63.491,316,079
$65.57+4.01+6.5%$61.74$66.93$61.741,932,805
$61.56+1.56+2.6%$60.42$62.84$60.151,590,636
$60.00+2.88+5.0%$57.12$62.56$56.812,382,968
$57.12+0.54+1.0%$58.19$59.49$56.602,669,091
$56.58-3.72-6.2%$60.16$60.23$53.544,338,300
$60.30+0.40+0.7%$60.67$61.73$60.002,123,400
$59.90-3.29-5.2%$62.60$63.44$58.982,441,300
$63.19-2.66-4.0%$65.17$65.69$62.861,497,800
$65.85-2.09-3.1%$67.40$67.52$65.031,050,100
$67.94+0.07+0.1%$67.78$68.53$66.911,277,700
$67.87+2.09+3.2%$64.74$69.08$63.232,590,800
$65.78-5.47-7.7%$70.52$73.51$64.153,156,300
$71.25-2.37-3.2%$74.28$76.29$70.321,563,200
$73.62+1.52+2.1%$72.71$74.60$69.001,718,400
$72.10-3.03-4.0%$75.21$75.44$70.681,421,100
$75.13-4.39-5.5%$78.38$79.18$75.001,096,800
$79.52+2.14+2.8%$81.30$88.68$77.842,555,300
$77.38-2.26-2.8%$79.64$80.52$77.251,221,600
$79.64+0.12+0.2%$79.44$80.02$77.09610,400
$79.52+0.15+0.2%$80.00$80.28$78.02657,200
$79.37-0.62-0.8%$79.73$80.19$77.071,237,700
$79.99-4.11-4.9%$84.93$85.05$79.40739,300
$84.10+0.10+0.1%$84.00$85.50$82.80540,200
$84.00+3.39+4.2%$81.37$84.33$80.26718,100
$80.61-4.30-5.1%$84.89$85.17$79.771,406,100
$84.91+2.33+2.8%$85.22$87.50$84.41692,100
$82.58-0.12-0.1%$83.33$84.07$81.54799,300
$82.70-0.83-1.0%$83.65$83.65$80.62783,500
$83.53+0.08+0.1%$83.45$84.91$82.491,645,900
$83.45-2.04-2.4%$86.38$87.01$83.24863,400
$85.49-4.59-5.1%$88.37$89.48$84.821,069,400
$90.08-2.94-3.2%$92.00$93.80$90.00708,300
$93.02-2.68-2.8%$93.62$97.43$92.61940,700
$95.70-0.73-0.8%$95.83$97.25$94.55515,500
$96.43+0.23+0.2%$97.11$98.00$94.92773,200
$96.20+4.22+4.6%$93.61$96.94$92.13818,200
$91.98+2.92+3.3%$89.00$92.85$88.641,161,800
$89.06+0.62+0.7%$87.61$89.81$86.99819,000
$88.44-4.80-5.1%$91.90$92.48$88.23610,300
$93.24-1.84-1.9%$95.06$95.06$92.54457,300
$95.08+2.81+3.0%$92.38$96.16$91.02655,400
$92.27+1.48+1.6%$92.47$94.33$91.68681,600
$90.79-2.74-2.9%$93.47$93.47$90.75514,107
$93.53+2.96+3.3%$91.39$95.46$90.51889,300
$90.57-3.08-3.3%$92.90$93.36$90.26936,900
Ticker
Frankfurt:7VR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Celcuity Inc. news

Celcuity Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 167 in all · newest Nov 9, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 5, 2026
Decks
36 decks · latest August 2026

Where Celcuity Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CELC · Home listingNASDAQUnited StatesUSD
BOATS:CELCBOATSUnited StatesUSD
gettex:7VRgettexGermanyEUR
Tradegate:7VRTradegateGermanyEUR
Frankfurt:7VR · This pageFrankfurtGermanyEUR
Munich:7VRMunichGermanyEUR
Dusseldorf:7VRDusseldorfGermanyEUR
Hamburg:7VRHamburgGermanyEUR
Hanover:7VRHanoverGermanyEUR
Lang & Schwarz:A2JAAXLang & SchwarzGermanyEUR
LS Exchange:A2JAAXLS ExchangeGermanyEUR
Xetra:7VRXetraGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.98B USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
1.10

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Celcuity Inc. · NASDAQ:CELCUS$2.62BUS$1.98Bn/an/an/an/an/an/a1.10
Dyne Therapeutics, Inc. · NASDAQ:DYNUS$2.90BUS$1.97Bn/an/an/a3.1×n/a0.2×1.51
Shanghai Junshi Biosciences Co., Ltd. Class A · SSE:688180US$2.88BUS$2.99Bn/a8.0×n/a3.2×−35.0%0.7×n/a
SELLAS Life Sciences Group, Inc. · NASDAQ:SLSUS$2.78BUS$2.65Bn/an/an/a21.1×n/a0.0×2.19
HLB Co., Ltd. · KRX:028300US$2.69BUS$2.69Bn/a36.9×n/a10.4×−219.1%0.2×n/a
Zai Lab Ltd. · HKEX:9688US$2.60BUS$2.04Bn/a4.6×n/a4.6×−44.9%0.0×n/a
Xencor, Inc. · NASDAQ:XNCRUS$2.50BUS$2.16Bn/a10.8×n/a4.5×−58.8%0.1×1.21
IDEAYA Biosciences, Inc. · NASDAQ:IDYAUS$2.47BUS$1.66Bn/a45.5×n/a2.3×n/a0.0×0.96
MBX Biosciences, Inc. · NASDAQ:MBXUS$2.46BUS$1.98Bn/an/an/a5.2×n/a0.0×1.30
Almirall SA · BME:ALMUS$2.45BUS$2.46B31.1×1.6×7.3×1.5×5.1%0.2×n/a
Keymed Biosciences, Inc. · HKEX:2162US$2.43BUS$2.04Bn/a19.6×n/a4.0×−73.0%0.2×n/a
Median of the othersUS$2.55BUS$2.10B31.1×10.8×7.3×4.3×−51.8%0.1×1.30

Forecasts

10 strong buy · 3 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
150.85 USD · Analysts' mean
EPS, year to Dec 2026
-4.28 · 2 analysts
Revenue, year to Dec 2026
13.64M · 11 analysts

Team and board

Officers

OfficerRole
Brian SullivanChief Executive Officer & Co-founder
Vicky HahneChief Financial Officer
Brent EilefsonGeneral Counsel and Chief Compliance Officer
Byron RobinsonChief Strategy Officer
Eldon MayerChief Commercial Officer
Igor GorbatchevskyChief Medical Officer
Lance LaingChief Science Officer & Co-founder

Board

DirectorRole
Charles R. RompDirector
David F. DalveyDirector
David W. GryskaDirector
Leo FurchtDirector
Polly MurphyDirector
Richard BullerDirector
Richard J. NigonDirector

Events

Calls

CallWhenStatus
Celcuity (NASDAQ:CELC) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2026 Earnings CallThu, Aug 13, 2026 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q1 2026 Earnings CallThu, May 14, 2026 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q4 2025 Earnings CallWed, Mar 25, 2026 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2025 Earnings CallWed, Nov 12, 2025 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2025 Earnings CallThu, Aug 14, 2025 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q1 2025 Earnings CallWed, May 14, 2025 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q4 2024 Earnings CallMon, Mar 31, 2025 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2024 Earnings CallThu, Nov 14, 2024 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2024 Earnings CallWed, Aug 14, 2024 · 4:30 PM ETReplay
All 25 calls
CallWhenStatus
Celcuity (NASDAQ:CELC) Q1 2024 Earnings CallWed, May 15, 2024 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q4 2023 Earnings CallWed, Mar 27, 2024 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2023 Earnings CallMon, Nov 13, 2023 · 8:00 AM ETReplay
Celcuity (NASDAQ:CELC) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q1 2023 Earnings CallMon, May 15, 2023 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q4 2022 Earnings CallThu, Mar 23, 2023 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2022 Earnings CallThu, Nov 10, 2022 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2022 Earnings CallThu, Aug 11, 2022 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q1 2022 Earnings CallMon, May 16, 2022 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q4 2021 Earnings CallWed, Mar 23, 2022 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2021 Earnings CallMon, Nov 08, 2021 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q1 2021 Earnings CallMon, May 10, 2021 · 4:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q3 2020 Earnings CallMon, Nov 09, 2020 · 3:30 PM ETReplay
Celcuity (NASDAQ:CELC) Q2 2020 Earnings CallMon, Aug 10, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+4.3%
Q2 2026Aug 13, 2026 · After close+6.2%
Q1 2026May 14, 2026 · After close+2.2%
Q4 2025Mar 19, 2026−5.8%
Q3 2025Nov 12, 2025 · After close+1.0%
Q2 2025Aug 14, 2025 · After close−0.2%
Q1 2025May 14, 2025 · After close−3.1%
Q4 2024Mar 25, 2025 · Before open−3.0%
Q3 2024Nov 14, 2024 · After close−10.3%
Q2 2024Aug 14, 2024 · After close−3.4%
All 20 quarters
QuarterResultsShare move
Q1 2024May 15, 2024 · After close+2.5%
Q4 2023Mar 27, 2024 · After close+18.9%
Q3 2023Nov 13, 2023 · Before open+1.1%
Q2 2023Aug 10, 2023 · After close−1.1%
Q1 2023May 15, 2023 · After close+3.0%
Q4 2022Mar 23, 2023 · After close−5.5%
Q3 2022Nov 10, 2022 · After close+3.5%
Q2 2022Aug 11, 2022 · After close−2.3%
Q1 2022May 16, 2022 · After close−2.8%
Q4 2021Mar 23, 2022 · After close−1.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck54 slidesAugust 2026
Corporate Update (July 2026)Corporate update22 slidesJul 15, 2026
Corporate Update (July 2026)Corporate update21 slidesJul 15, 2026
ASCO 2026 Annual MeetingConference19 slidesJun 2, 2026
Investor Conference Call (June 2026)Conference39 slidesJun 2, 2026
2025 San Antonio Breast Cancer Symposium (SABCS)Conference18 slidesDec 11, 2025
Investor Presentation (November 2025)Investor deck54 slidesNovember 2025
Technical Presentation (October 2025)Technical22 slidesOct 20, 2025
Technical Presentation (October 2025)Technical18 slidesOct 18, 2025
Investor Presentation (October 2025)Investor deck54 slidesOctober 2025
All 36 decks
DeckKindSlidesDate
Investor Presentation (October 2025)Investor deck54 slidesOctober 2025
Investor Presentation (August 2025)Investor deck50 slidesAugust 2025
Investor Presentation (July 2025)Investor deck55 slidesJuly 2025
Investor Presentation (June 2025)Investor deck55 slidesJune 2025
Investor Presentation (May 2025)Investor deck54 slidesMay 2025
Investor Presentation (March 2025)Investor deck54 slidesMarch 2025
Investor Presentation (December 2024)Investor deck54 slidesDecember 2024
Investor Presentation (November 2024)Investor deck53 slidesNovember 2024
Investor Presentation (August 2024)Investor deck53 slidesAugust 2024
Investor Presentation (June 2024)Investor deck53 slidesJune 2024
Investor Presentation (March 2024)Investor deck56 slidesMarch 2024
Investor Presentation (March 2024)Investor deck57 slidesMarch 2024
Investor Presentation (January 2024)Investor deck56 slidesJanuary 2024
Investor Day (September 2023)Investor day96 slidesSep 21, 2023
Investor Presentation (September 2023)Investor deck56 slidesSeptember 2023
Investor Presentation (May 2023)Investor deck43 slidesMay 2023
Investor Presentation (March 2023)Investor deck43 slidesMarch 2023
Investor Presentation (February 2023)Investor deck43 slidesFebruary 2023
Investor Presentation (December 2022)Investor deck42 slidesDecember 2022
Investor Presentation (November 2022)Investor deck41 slidesNovember 2022
Investor Presentation (August 2022)Investor deck41 slidesAugust 2022
Investor Presentation (June 2022)Investor deck41 slidesJune 2022
Investor Presentation (May 2022)Investor deck41 slidesMay 16, 2022
Investor Presentation (March 2022)Investor deck41 slidesMar 23, 2022
Investor Presentation (August 2021)Investor deck38 slidesAug 9, 2021
Investor Presentation (June 2021)Investor deck37 slidesJun 28, 2021

Open Decks

Financings

RaiseDate
2.750% convertible senior notes due 2031
Made bigger: US$175M · Jefferies +4
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), LifeSci Capital, ICR Capital LLC
Use of proceeds: Working capital and general corporate purposes, including clinical trials, commercial launch, R&D, capital expenditures and business development
Jul 30, 2025
Public offering of common stock and pre-funded warrants
Update: US$75M · US$38 a share · Jefferies +3
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Leerink Partners (co-lead), LifeSci Capital
Use of proceeds: Working capital and general corporate purposes, including clinical trials, commercial launch, R&D, capital expenditures and business development
Jul 30, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$9.50 a share on Sep 19, 2017.

Price
US$9.50 a share
Shares offered
2,400,000 shares of common stock
Offering size
US$22.8 million
Underwriters' option
Up to 360,000 more shares
Listing
CELC on the Nasdaq Capital Market
Underwriter
Craig-Hallum Capital Group
Shares delivered
On or about Sep 22, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceJun 12, 2017
Filed publiclyAug 23, 2017
Amended 3 timesNewest Sep 12, 2017
Shares registered with an exchangeSep 15, 2017
Declared effective by the SECSep 19, 2017
Final prospectus, with the priceSep 20, 2017

Open IPO · From the cover of the final prospectus (424B4) filed Sep 20, 2017

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue154.0K000000000
Cost of revenue167.0K129.9K142.8K210.9K303.2K385.6K339.0K223.0K104.7K73.1K
Gross profit-167.0K-129.9K-142.8K-210.9K-303.2K-385.6K-339.0K-223.0K-104.7K-73.1K
Research and development145.0M104.2M60.6M35.3M25.8M7.68M6.27M6.33M4.98M3.06M
Selling, general and administrative27.2M9.06M5.64M4.10M2.60M1.87M1.54M1.61M972.5K263.7K
Operating income-172.2M-113.3M-66.2M-39.4M-28.4M-9.56M-7.81M-7.93M-5.95M-3.33M
Depreciation and amortization167.0K130.0K142.8K210.9K303.2K385.6K339.0K223.0K104.7K73.1K
EBITDA-172.0M-113.1M-66.1M-39.2M-28.1M-9.17M-7.47M-7.71M-5.85M-3.26M
Interest expense17.1M10.3M5.33M2.11M1.26M120159111451.7K0
Income before tax-177.0M-111.8M-63.8M-40.4M-29.6M-9.47M-7.36M-7.48M-6.25M-3.31M
Income tax-3978.9K959.1K00000
Net income-177.0M-111.8M-63.8M-40.4M-29.6M-9.47M-7.36M-7.48M-6.25M-3.31M
Earnings per share, basic-3.79-2.83-2.69-2.64-2.21-0.92-0.72-0.74-0.84-0.52
Earnings per share, diluted-3.79-2.83-2.69-2.64-2.21-0.92-0.72-0.74-0.84-0.52

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents165.7M22.5M30.7M24.6M84.3M11.6M18.7M15.9M2.69M5.86M
Short-term investments275.8M212.6M149.9M144.0M2222.0K08.95M21.6M0
Receivables1.60M805.9K203.7K298.8K190.0K190.0K
Inventory-8.63M-203.7K-298.8K-190.0K-190.0K0
Current assets465.7M244.6M190.6M175.2M85.4M12.2M19.3M25.2M24.5M5.91M
Property, plant and equipment499.0K336.0K228.8K260.3K312.4K558.9K833.5K813.6K280.1K144.9K
Goodwill0
Total assets466.6M245.1M191.2M175.7M85.9M13.0M20.3M26.0M32.0M6.06M
Accounts payable6.41M9.37M5.08M2.63M1.51M217.4K142.8K119.8K71.9K331.5K
Current liabilities44.2M31.7M14.2M6.88M2.51M1.19M911.3K662.3K578.1K445.4K
Long-term debt321.9M97.7M37.0M35.0M14.6M0
Total debt137.5M105.1M37.6M35.8M16.0M262.5K256.1K25.6K
Total liabilities366.0M129.5M51.5M41.9M17.2M1.25M983.2K682.2K578.1K445.4K
Shareholders' equity100.6M115.6M139.8M133.8M68.7M11.7M19.3M25.3M31.4M5.61M
Shares outstanding48.2M37.1M25.5M21.7M14.9M10.3M10.3M10.2M10.1M0

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-153.3M-83.5M-53.8M-36.0M-20.3M-7.15M-6.00M-6.08M-4.95M-2.89M
Capital spending-249.0K-250.0K-97.6K-158.8K-81.9K-89.4K-380.2K-629.6K-239.8K-40.9K
Free cash flow-153.5M-83.7M-53.9M-36.2M-20.4M-7.24M-6.38M-6.71M-5.19M-2.93M
Cash from investing-64.1M-63.1M-5.01M-144.0M-81.4K-89.4K8.53M19.1M-29.0M-40.9K
Cash from financing360.6M138.4M64.9M120.3M93.0M138.0K259.3K236.7K30.7M3.72M
Dividends paid0
Share buybacks95.9M82.2K60.3K266.3K-55.1K24.1M3.72M
Change in cash143.2M-8.15M6.09M-59.7M72.6M-7.10M2.79M13.3M-3.22M789.1K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
4 · Change in ownershipOct 9, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 5, 2026Insider tradeSEC
8-K · Current reportOct 2, 2026Management or board changeSEC
8-K · Current reportSep 30, 2026Current reportSEC
8-K · Current reportAug 26, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 11, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJul 16, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 16, 2026Big-stake noticeSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
8-K/A · Current report, amendedJul 15, 2026Current reportSEC
144 · Notice of proposed saleJul 14, 2026Other filingsSEC
144 · Notice of proposed saleJul 14, 2026Other filingsSEC
8-K · Current reportJul 14, 2026Current reportSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Material contractSEC
424B5 · ProspectusJun 5, 2026Offer documentSEC
305B2Jun 5, 2026Other filingsSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
FWP · Free writing prospectusJun 4, 2026Offer documentSEC
424B5 · ProspectusJun 3, 2026Offer documentSEC
8-K · Current reportJun 2, 2026Current reportSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
8-K/A · Current report, amendedMay 20, 2026Management or board changeSEC
S-8 · Registration statement for employee plansMay 18, 2026Offer documentSEC
8-K · Current reportMay 18, 2026Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
144 · Notice of proposed saleMay 4, 2026Other filingsSEC
8-K · Current reportMay 1, 2026Current reportSEC
4 · Change in ownershipApr 13, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 2, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 2, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 2, 2026Meeting noticeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
144 · Notice of proposed saleMar 31, 2026Other filingsSEC
10-K · Annual reportMar 26, 2026Annual reportSEC
8-K · Current reportMar 25, 2026ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 24, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 9, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 13, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 13, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
8-K · Current reportFeb 12, 2026Management or board changeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
144 · Notice of proposed saleJan 27, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 16, 2026Big-stake noticeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
S-3ASR · Registration statementJan 9, 2026Offer documentSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
144 · Notice of proposed saleDec 5, 2025Other filingsSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
144 · Notice of proposed saleNov 20, 2025Other filingsSEC
8-K · Current reportNov 17, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
8-K · Current reportOct 20, 2025Current reportSEC
D/ASep 23, 2025Other filingsSEC
4 · Change in ownershipSep 15, 2025Insider tradeSEC
4 · Change in ownershipSep 10, 2025Insider tradeSEC
8-K · Current reportSep 10, 2025Material contractSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 18, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 4, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2025Big-stake noticeSEC
3 · Initial statement of ownershipAug 1, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeAug 1, 2025Big-stake noticeSEC
8-K · Current reportAug 1, 2025Material contractSEC
305B2Jul 31, 2025Other filingsSEC
8-K · Current reportJul 31, 2025Material contractSEC
424B5 · ProspectusJul 31, 2025Offer documentSEC
424B5 · ProspectusJul 31, 2025Offer documentSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
FWP · Free writing prospectusJul 30, 2025Offer documentSEC
FWP · Free writing prospectusJul 30, 2025Offer documentSEC
424B5 · ProspectusJul 29, 2025Offer documentSEC
8-K · Current reportJul 29, 2025Material contractSEC
424B5 · ProspectusJul 28, 2025Offer documentSEC
424B5 · ProspectusJul 28, 2025Offer documentSEC
144 · Notice of proposed saleJul 28, 2025Other filingsSEC
144 · Notice of proposed saleJul 28, 2025Other filingsSEC
8-K · Current reportJul 28, 2025Current reportSEC
8-K · Current reportJun 30, 2025Current reportSEC
S-8 · Registration statement for employee plansJun 4, 2025Offer documentSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
8-K · Current reportMay 16, 2025Management or board changeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportMay 14, 2025ResultsSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 7, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 1, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2025Meeting noticeSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 31, 2025ResultsSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipFeb 18, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 4, 2025Big-stake noticeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
8-K · Current reportDec 6, 2024Current reportSEC
424B5 · ProspectusDec 6, 2024Offer documentSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 3, 2024Other filingsSEC
CORRESP · Letter to the SECNov 27, 2024Other filingsSEC
S-3/A · Registration statement, amendedNov 26, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
8-K · Current reportNov 14, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
4 · Change in ownershipOct 25, 2024Insider tradeSEC
D/AOct 15, 2024Other filingsSEC
8-K · Current reportOct 9, 2024Meeting outcomeSEC
SC 13G/A · Big-stake notice, amendedOct 7, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECSep 6, 2024Other filingsSEC
S-3 · Registration statementAug 30, 2024Offer documentSEC
DEFA14A · Additional proxy materialAug 28, 2024Meeting noticeSEC
DEF 14A · Proxy statementAug 28, 2024Meeting noticeSEC
4 · Change in ownershipAug 27, 2024Insider tradeSEC
4/A · Change in ownership, amendedAug 26, 2024Insider tradeSEC
4/A · Change in ownership, amendedAug 26, 2024Insider tradeSEC
144 · Notice of proposed saleAug 23, 2024Other filingsSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
PRE 14A · Preliminary proxy statementAug 16, 2024Meeting noticeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 14, 2024ResultsSEC
D/AJun 28, 2024Other filingsSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
SC 13G · Big-stake noticeJun 10, 2024Big-stake noticeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
8-K · Current reportMay 31, 2024Material contractSEC
424B5 · ProspectusMay 30, 2024Offer documentSEC
8-K · Current reportMay 30, 2024Material contractSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
S-8 · Registration statement for employee plansMay 20, 2024Offer documentSEC
10-Q · Quarterly reportMay 15, 2024Quarterly reportSEC
8-K · Current reportMay 15, 2024ResultsSEC
8-K · Current reportMay 13, 2024Management or board changeSEC
4 · Change in ownershipApr 30, 2024Insider tradeSEC
4 · Change in ownershipApr 26, 2024Insider tradeSEC
D/AApr 25, 2024Other filingsSEC
144 · Notice of proposed saleApr 24, 2024Other filingsSEC
4 · Change in ownershipApr 10, 2024Insider tradeSEC
8-K · Current reportMar 29, 2024Material contractSEC
ARS · Annual report to shareholdersMar 29, 2024Annual reportSEC
DEFA14A · Additional proxy materialMar 28, 2024Meeting noticeSEC

This page holds 200 of 544 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Celcuity Inc.’s releases · as of Oct 29, 2026

Common shares
49,126,314
Fully diluted
49,126,314

Fully diluted

LineSharesAs of
Common shares49,126,314Oct 29, 2026

Share count over time

CountShares
Oct 29, 202649,126,314

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Baker Bros. Advisors LP4.82MUS$383MSep 30, 2026
Rtw Investments, LP3.3MUS$263MSep 30, 2026
Perceptive Advisors LLC3.18MUS$253MSep 30, 2026
BlackRock3.18MUS$253MSep 30, 2026
Vanguard2.64MUS$210MSep 30, 2026
Deerfield Management Company, L.P.2.4MUS$191MSep 30, 2026
State Street2.06MUS$164MSep 30, 2026
Point72 Asset Management, L.P.1.76MUS$140MSep 30, 2026
NEA Management Company, LLC1.71MUS$136MSep 30, 2026
Bank of America1.71MUS$136MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Soleus Capital Management, L.P.1.68MUS$134MSep 30, 2026
Morgan Stanley1.53MUS$122MSep 30, 2026
Avoro Capital Advisors LLC1.5MUS$119MSep 30, 2026
Assenagon Asset Management S.A.1.48MUS$118MSep 30, 2026
Tang Capital Management LLC1.46MUS$116MSep 30, 2026
Hood River Capital Management LLC1.29MUS$103MSep 30, 2026
TD1.26MUS$100MSep 30, 2026
Wellington1.1MUS$87.3MSep 30, 2026
Geode Capital1.03MUS$81.7MSep 30, 2026
Goldman Sachs1MUS$79.8MSep 30, 2026
Silverarc Capital Management, LLC803KUS$63.9MSep 30, 2026
Holocene Advisors, LP755KUS$60MSep 30, 2026
Citadel600KUS$47.7MSep 30, 2026
Apis Capital Advisors, LLC567KUS$45.1MSep 30, 2026
Fuller & Thaler Asset Management, Inc.546KUS$43.4MSep 30, 2026
Fidelity540KUS$42.9MSep 30, 2026
BNP Paribas524KUS$41.7MSep 30, 2026
Saturn V Capital Management LP514KUS$40.9MSep 30, 2026
AllianceBernstein503KUS$40MSep 30, 2026
Franklin Templeton493KUS$34.1MSep 30, 2026
T. Rowe Price487KUS$38.8MSep 30, 2026
Two Sigma458KUS$36.4MSep 30, 2026
American Century446KUS$35.5MSep 30, 2026
UBS435KUS$34.6MSep 30, 2026
Jones Hill Capital LP383KUS$30.4MSep 30, 2026
Northern Trust374KUS$29.8MSep 30, 2026
Schwab360KUS$28.7MSep 30, 2026
First Turn Management, LLC329KUS$26.2MSep 30, 2026
Orbimed Advisors LLC315KUS$25MSep 30, 2026
Jennison Associates LLC300KUS$23.9MSep 30, 2026
Pfizer Inc296KUS$23.5MSep 30, 2026
Pictet Asset Management Holding SA291KUS$23.1MSep 30, 2026
Voya Investment Management LLC289KUS$23MSep 30, 2026
Boxer Capital Management, LLC286KUS$22.8MSep 30, 2026
Artisan Partners Limited Partnership248KUS$19.7MSep 30, 2026
Woodline Partners LP241KUS$19.1MSep 30, 2026
Fiera Capital Corp237KUS$18.8MSep 30, 2026
Focus Partners Wealth233KUS$18.5MSep 30, 2026
Catalio Capital Management, LP231KUS$18.3MSep 30, 2026
Nomura221KUS$17.6MSep 30, 2026

This page holds 50 of 261 holders. Open Shareholders

Funds

HolderSharesValueAs of
Vanguard Total Stock Market Index Fund1.39MUS$146MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1.13MUS$118MJun 30, 2026
iShares Russell 2000 ETF988KUS$103MJun 30, 2026
Vanguard Extended Market Index Fund436KUS$45.6MJun 30, 2026
Fidelity Small Cap Index Fund421KUS$36.3MJul 31, 2026
Select Biotechnology Portfolio376KUS$49.9MMay 31, 2026
iShares Russell 2000 Growth ETF355KUS$37.2MJun 30, 2026
Fullerthaler Behavioral Small-Cap Growth350KUS$36.6MJun 30, 2026
Small Cap Growth Fund339KUS$29.3MJul 31, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund290KUS$30.3MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
Artisan International Small-Mid Fund286KUS$29.9MJun 30, 2026
T. Rowe Price New Horizons Fund, Inc.270KUS$28.3MJun 30, 2026
Hood River Small-Cap Growth Fund223KUS$23.3MJun 30, 2026
Eventide Healthcare & Life Sciences Fund196KUS$20.5MJun 30, 2026
Fidelity Extended Market Index Fund185KUS$24.6MMay 31, 2026
Vanguard Russell 2000 Index Fund180KUS$23.9MMay 31, 2026
Schwab U.S. Small-Cap ETF173KUS$23MMay 31, 2026
AB Small Cap Growth Portfolio163KUS$17MJun 30, 2026
Nomura Small Cap Growth Fund138KUS$14.4MJun 30, 2026
Franklin Small Cap Growth Fund113KUS$9.75MJul 31, 2026
PGIM Jennison Health Sciences Fund111KUS$14.8MMay 29, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund110KUS$9.52MJul 31, 2026
Putnam Small Cap Growth Fund103KUS$10.8MJun 30, 2026
Schwab Small-Cap Index Fund93,244US$8.05MJul 31, 2026
Vanguard Explorer Fund71,900US$6.21MJul 31, 2026
Master Small Cap Index Series70,755US$7.4MJun 30, 2026
Voya Small Cap Growth Fund69,266US$9.2MMay 31, 2026
Fidelity Total Market Index Fund68,273US$9.07MMay 31, 2026
EQ/AB Small Cap Growth Portfolio66,716US$6.98MJun 30, 2026
Vanguard Health Care Index Fund62,506US$8.31MMay 31, 2026
Fidelity Enhanced Small Cap Core ETF59,364US$6.21MJun 30, 2026
Fidelity Series Total Market Index Fund55,372US$7.36MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF50,872US$5.32MJun 30, 2026
Hood River New Opportunities Fund50,414US$5.27MJun 30, 2026
Nuveen Small Cap Blend Index Fund49,657US$4.29MJul 31, 2026
T. Rowe Price Health Sciences Fund, Inc.49,300US$5.16MJun 30, 2026
ClearBridge Small Cap Fund49,192US$4.25MJul 31, 2026
Small Cap Growth Stock Portfolio49,119US$5.14MJun 30, 2026
Victory Small Cap Stock Fund48,090US$4.15MJul 31, 2026
Driehaus Micro Cap Growth Fund47,852US$5.01MJun 30, 2026
ALPS Medical Breakthroughs ETF47,693US$6.34MMay 31, 2026
Tema Oncology ETF47,450US$6.31MMay 31, 2026
Franklin Biotechnology Discovery Fund46,107US$3.98MJul 31, 2026
SmallCap Growth Fund I43,712US$3.78MJul 31, 2026
Carillon Eagle Small Cap Growth Fund41,868US$4.38MJun 30, 2026
EQ/2000 Managed Volatility Portfolio41,800US$4.37MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund40,807US$4.27MJun 30, 2026
JNL Multi-Manager Small Cap Growth Fund38,350US$4.01MJun 30, 2026
Direxion Daily S&P Biotech Bull 3X Shares38,241US$3.3MJul 31, 2026
iShares U.S. Small-Cap Equity Factor ETF38,140US$3.29MJul 31, 2026

This page holds 50 of 245 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Julian C. Baker
Other: Former 10% owner
Sale261,368USD 102.50US$26.8MJul 14, 2026
Julian C. Baker
Other: Former 10% owner
Sale2,838,632USD 102.50US$291MJul 14, 2026
Dalvey David
Director
Sale25,000USD 140.68US$3.52MMay 4, 2026
Buller Richard E
Director
Sale1,289USD 137.00US$177KMay 4, 2026
Buller Richard E
Director
Sale550USD 139.00US$76,450May 4, 2026
Buller Richard E
Director
Sale1,670USD 139.58US$233KMay 4, 2026
Buller Richard E
Director
Sale2,301USD 141.03US$325KMay 4, 2026
Buller Richard E
Director
Sale2,825USD 142.04US$401KMay 4, 2026
Buller Richard E
Director
Sale365USD 143.24US$52,283May 4, 2026
Buller Richard E
Director
Sale2,325USD 110.11US$256KMar 31, 2026
All 11 trades
TradeTradeSharesPriceValueDate
Buller Richard E
Director
Sale675USD 110.83US$74,810Mar 31, 2026

Big stakes

StakeStakeSharesDateFiling
Baker Bros. Advisors LP9.99%4.88MJul 14, 2026Schedule 13G
Soleus Capital Master Fund, L.P.9.90%3.87MDec 31, 2024Schedule 13G
Brian F. Sullivan9.10%4.01MSep 30, 2025Schedule 13G
Perceptive Advisors LLC6.80%3.16MDec 31, 2025Schedule 13G
Rtw Investments, LP6.30%3.04MMar 31, 2026Schedule 13G
BlackRock, Inc.5.90%2.18MDec 31, 2024Schedule 13G
Growth Equity Opportunities 18 VGE, LLC4.90%2.29MMar 5, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David W. Gryska
Other companies: Forte Biosciences, Inc. (Director · Since at least Aug 27, 2026); Definium Therapeutics, Inc. (Director · Since at least Jun 11, 2026)
Director · Since at least Oct 1, 2026
Charles R. Romp
Other companies: Seagen Inc (EVP, Commercial U.S. · Apr 15, 2020 – Dec 14, 2023 · Past)
Director · Since at least Feb 11, 2026
Polly A. Murphy
Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Mar 26, 2025)
Director · Since at least Jun 24, 2024
Richard J. Nigon
Other companies: Northern Technologies International Corporation (Director · Since at least Jul 20, 2026)
Director · Since at least Apr 9, 2026
Brent EilefsonGeneral Counsel and Chief Compliance Officer · Since at least Nov 5, 2026
Brian SullivanChief Executive Officer & Co-founder · Since at least Aug 18, 2026
Byron RobinsonChief Strategy Officer · Since at least Nov 5, 2026
David F. DalveyDirector · Since at least Jun 9, 2026
Eldon MayerChief Commercial Officer · Since at least Nov 5, 2026
Igor GorbatchevskyChief Medical Officer · Since at least Sep 30, 2026
All 16 people
PersonSeat
Lance LaingChief Science Officer & Co-founder · Since at least Aug 18, 2026
Leo T. FurchtDirector · Since at least May 16, 2019
Maureen Therese CroninDirector · Sep 19, 2017 – May 16, 2019 · Past
Richard E. BullerDirector · Since at least Apr 20, 2022
Vicky HahneChief Financial Officer · Since at least Aug 18, 2026
Vicky HahneChief Financial Officer · Since at least Jul 5, 2018

Open People

Log in to ask 6ix AI your own questions about Celcuity Inc.